Cargando…
A Conserved Role for LRRK2 and Roco Proteins in the Regulation of Mitochondrial Activity
Parkinson’s Disease (PD) is the second most common neurodegenerative disease world-wide. Mutations in the multidomain protein Leucine Rich Repeat Kinase 2 (LRRK2) are the most frequent cause of hereditary PD. Furthermore, recent data suggest that independent of mutations, increased kinase activity o...
Autores principales: | Rosenbusch, Katharina E., Oun, Asmaa, Sanislav, Oana, Lay, Sui T., Keizer-Gunnink, Ineke, Annesley, Sarah J., Fisher, Paul R., Dolga, Amalia M., Kortholt, Arjan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455996/ https://www.ncbi.nlm.nih.gov/pubmed/34568343 http://dx.doi.org/10.3389/fcell.2021.734554 |
Ejemplares similares
-
The LRRK2-related Roco kinase Roco2 is regulated by Rab1A and controls the actin cytoskeleton
por: Kicka, Sebastian, et al.
Publicado: (2011) -
Roco Proteins: GTPases with a Baroque Structure and Mechanism
por: Wauters, Lina, et al.
Publicado: (2019) -
Characterization of Lipopolysaccharide Effects on LRRK2 Signaling in RAW Macrophages
por: Oun, Asmaa, et al.
Publicado: (2023) -
The tale of proteolysis targeting chimeras (PROTACs) for Leucine‐Rich Repeat Kinase 2 (LRRK2)
por: Konstantinidou, Markella, et al.
Publicado: (2020) -
Activation Mechanism of LRRK2 and Its Cellular Functions in Parkinson's Disease
por: Rosenbusch, Katharina E., et al.
Publicado: (2016)